Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome)
The relationship between the pathophysiology of osteoarthritis (OA) and metabolic disorders (metabolic syndrome, obesity) is provided not only by mechanical causes (increased body weight pressure on the joints). A complex of molecular mechanisms, which mediates OA effect on the development of obesit...
Saved in:
Main Authors: | I. Yu. Torshin (Author), О. A. Gromova (Author), A. M. Lila (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022) -
Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system
by: I. Yu. Torshin, et al.
Published: (2020) -
Perioperative pharmacotherapy for endoprosthetics: potential of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022) -
Oncoprotective effects of chondroprotectors: glucosamine, chondroitin sulfate and undenatured type II collagen
by: I. Yu. Torshin, et al.
Published: (2024) -
Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis
by: Francisco J. Blanco, et al.
Published: (2019)